Effect of sodium-glucose cotransporter-2 inhibitors on myocardial infarction incidence: A systematic review and meta-analysis of randomized controlled trials and cohort studies.
Xiaoru HuangEstau DannyaXuening LiuYang YuPanhui TianZijian LiPublished in: Diabetes, obesity & metabolism (2023)
In both RCTs and cohort studies, SGLT2 inhibitors reduced MI incidence. The cardioprotective effects of SGLT2 inhibitors were observed in patients with and without a history of CVD.